InvestorsHub Logo
Followers 60
Posts 7400
Boards Moderated 0
Alias Born 10/20/2014

Re: Bluensleepy post# 307684

Sunday, 11/01/2020 9:53:27 AM

Sunday, November 01, 2020 9:53:27 AM

Post# of 426455
It's not the price suppression that has me consternated...it is the lack
of any reasonable speculation about the potential (and very likely)
health benefits that Vascepa has!

Here is another way to frame my question. Is Vascepa more valuable
because of COVID-19 or less valuable? I would argue more valuable
for obvious reasons. Why AMRN management did not jump on this from
the get-go...Seems rather obvious that the most vulnerable to the
worst effects of the virus are the same as those most at risk for
CVD. Logically, if one is at risk from "2"" life destroying threats,
CVD and COVID-19, and the possibility exists that the protection with
certainty from one, (CVD) may just help you with protection from the
other, (COVID-19) it would seem a no-brainer as to what one would do.

Certainly, on this planet there must be some individuals who understand
this and are aware of the potential that Vascepa in a post COVID-19
world. (My hope, of course, is that some of those individuals have
some influence with a Eurocentric BP.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News